Jul 23, 2024 | Federal Trade Commission (FTC), Formularies, News, Pharmacy Benefits Manager (PBM)
In an interim report released on July 9, the Federal Trade Commission charges major pharmacy benefit managers of engaging in business practices designed to benefit their own bottom lines at the expense of clients. The FTC report, subtitled “The Powerful...
Oct 18, 2022 | Formularies, MedBen Rx, Pharmacy Benefits Manager (PBM), Rx Costs, Rx Spending, Savings, White paper
Major pharmacy benefit managers (PBMs) use “smoke and mirrors” to make you believe they’re saving you money on prescription drugs: On the one hand, PBMs offer you administrative fee credits – fixed cost reductions that make up just a small...
Aug 8, 2022 | Comparative Effectiveness, Drug marketing, Formularies, MedBen Rx, Pharmacy Benefits Manager (PBM), Rebates
From Benefits Pro: “The median launch price of a new drug in the US soared from $2,115 in 2008 to $180,007 in 2021, a 20% annual inflation rate over the period, researchers at Harvard-affiliated Brigham and Women’s Hospital in Boston found.”Contributing to these...
Jul 12, 2022 | Formularies, MedBen Rx, Pharmacy Benefits Manager (PBM), Rebates, Rx prices, Savings, White paper
MedBen Rx has prepared a whitepaper detailing the games pharmacy benefit managers (PBMs) play with administrative and rebate credits. PBMs focus on fixed cost savings to make you think you’re saving on prescription costs… but a closer look reveals that you’re...
Jun 1, 2021 | Formularies, MedBen Rx, Pharmacy Benefits Manager (PBM), Prescription drugs, Savings, Transparency
MedBen Rx clients save 21.6% when switching from traditional PBMs. What accounts for such a substantial difference? With MedBen Rx you pay what the pharmacy pays – we use the drug’s acquisition cost as a baseline to reduce your costs. MedBen Rx offers total...
